Mendelian randomization analyses link insomnia with higher generalized epilepsy risk, suggesting sleep traits as modifiable targets for seizure control and personalized epilepsy management strategies ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present new data on cenobamate, an ...

Covenant Health recently announced another addition to its treatment options for neurological disorders. Responsive Neurostimulation (RNS) is bringing new hope to patients across West Texas and ...

Epilepsy surgery has been shown to be an effective treatment for patients with intractable epilepsy. The only randomized controlled trial conducted in this setting to date found a dramatic advantage ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Researchers led by St Michael's Hospital in Toronto report that ketogenic diets are associated with modest reductions in ...

TWENTY-SEVEN medical conditions and health issues have been identified by the Philippine Health Insurance Corporation (PhilHealth) as eligible for coverage unde ...

Besides the amygdala, another important region of the brain, known as the hippocampus, is also involved in the fear response.

Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start of therapy ...